Latest filing published 17 Mar 2026 for BioSyent Inc., €7,233.
Marnie Mccormick appears in our data through filings on BioSyent Inc. shares, published by SEDI. Over a trading history stretching from 17 June 2024 to 31 December 2025, the count stands at 5 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 17 March 2026 came the latest disclosure, a share grant for €7,233 in BioSyent Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations